Clinical Trial

Effect of Locally Produced Mango Variety on Glycemic Index

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized trial aims to assess the glycemic index (GI) of locally available mango varieties in healthy adult participants, using glucose as the reference food. The study will evaluate the postprandial blood glucose response elicited by selected mango varieties and compare it to the response produced by a standard glucose . The objective is to determine whether certain mango varieties have a lower glycemic impact, which may be relevant for dietary planning and public health recommendations.
Trial Details
NCT Number NCT07015827
Lead Sponsor Rehman Medical Institute - RMI
Conditions Glycemic Index and Glycemic Load
Enrollment 30 participants
Start Date 2025-06
Primary Completion 2025-08 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-06-11